Companies: 10,795·Total market cap: $144.5T
Hard to Treat Diseases Inc.

Hard to Treat Diseases Inc.

HTDSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$109647
P/E Ratio—
52W High$0.00002
52W Low$0.000001
Overview

Hard to Treat Diseases Inc. (HTDS) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

HTDS · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.
No analyst estimates available for HTDS.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: HTDS ends December

Hard to Treat Diseases Inc. (HTDS) reports earnings quarterly as a OTC-listed Biotechnology company. The next HTDS earnings date is expected around September 1, 2026.

Each quarter, investors track HTDS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HTDS revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HTDS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

HTDS earnings · 3 questions

Hard to Treat Diseases Inc.'s next earnings report is expected around September 1, 2026. HTDS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HTDS historically reports after market close (AMC).

HTDS earnings datewhen is HTDS earningsHTDS next earnings datewhen does HTDS report earningsHTDS earnings calendar

▸ Source: FMP · Hard to Treat Diseases Inc. SEC filings · US GAAP · Hard to Treat Diseases Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026